Benitec Biopharma
Stock Forecast, Prediction & Price Target
Benitec Biopharma (BNTC) stock Price Target by analysts
$20.33
Potential upside: 61.88%
Benitec Biopharma price prediction
What is Benitec Biopharma stock analysts` prediction?
Benitec Biopharma stock forecast: Based on 3 Wall Street analysts` predicted price targets for Benitec Biopharma in the last 3 months, the avarage price target is $20.33, with a high forecast of $NaN. The average price target represents a 61.88% change from the last price of $12.56.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Benitec Biopharma stock Price Target by analysts
Full breakdown of analysts given Benitec Biopharma price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Mani Foroohar Leerink Partners | 0% 0/1 | 11 months ago | $13 3.50% upside | $10.86 | StreetInsider | Previous targets (0) |
Silvan Tuerkcan JMP Securities | 0% 0/1 | 11 months ago | $18 43.31% upside | $10.86 | TheFly | Previous targets (0) |
Yasmeen Rahimi Piper Sandler | 0% 0/1 | 12 months ago | $30 138.85% upside | $8.88 | StreetInsider | Previous targets (0) |
Benitec Biopharma Financial Estimates
Benitec Biopharma Revenue Estimates
Benitec Biopharma EBITDA Estimates
Benitec Biopharma Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2026 | 6/30/2027 | 6/30/2028 | |
Revenue
% change YoY
| $73K N/A | $75K 2.73% | $216K 188% | Avg: $28.03K Low: $28.03K High: $28.03K avg. -87.01% | Avg: $96.09M Low: $96.09M High: $96.09M avg. 342638.27% | Avg: $39.64M Low: $39.64M High: $39.64M avg. -58.74% | |
Net Income
% change YoY
| $-18.56M N/A | $-19.56M -5.38% | $-21.75M -11.19% | Avg: $-34.10M Low: $-6.44M High: $-6.44M avg. -56.81% | Avg: $-5.72M Low: $-5.72M High: $-5.72M avg. 83.20% | Avg: $597.63K Low: $597.63K High: $597.63K avg. 110.43% | |
EBITDA
% change YoY
| $-17.93M N/A | $-18.7M -4.27% | $-22.49M -20.26% | Avg: $-21.36K Low: $-21.36K High: $-21.36K avg. 99.90% | Avg: $-73.21M Low: $-73.21M High: $-73.21M avg. -342645.49% | Avg: $-30.20M Low: $-30.20M High: $-30.20M avg. 58.74% | |
EPS
% change YoY
| -$38.62 N/A | -$14.12 63.43% | -$5.36 62.03% | Avg: -$4.65 Low: -$4.65 High: -$4.65 avg. 13.20% | Avg: -$4.13 Low: -$4.13 High: -$4.13 avg. 11.13% | Avg: $0.43 Low: $0.43 High: $0.43 avg. 110.43% | |
Operating Expenses
% change YoY
| $17.91M N/A | $19.15M 6.90% | $22.38M 16.84% | Avg: $1.93M Low: $1.93M High: $1.93M avg. -91.36% | Avg: $6.62B Low: $6.62B High: $6.62B avg. 342638.28% | Avg: $2.73B Low: $2.73B High: $2.73B avg. -58.74% | |
FAQ
What is Benitec Biopharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 45.60% in 2026-2028.
We have gathered data from 1 analysts. Their low estimate is -6.44M, average is -34.10M and high is -6.44M.
What is Benitec Biopharma stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 114164.16% in 2026-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $28.03K, average is $28.03K and high is $28.03K.
What is Benitec Biopharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 44.92% in 2026-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$4.65, average is -$4.65 and high is $-4.65.
What is the best performing analyst?
In the last twelve months 3 analysts have been covering Benitec Biopharma stock. The most successful analyst is Mani Foroohar.